Damora Therapeutics (DMRA) Gains (Losses) on Sale of Assets & Investments (2021 - 2026)
Damora Therapeutics (DMRA) posted Non Operating Investment Income of $2,000 for Q2 2024, down 92.0% from $25,000 a year earlier and down 93.8% from the prior quarter.
Powered by 
Analysis
Damora Therapeutics (DMRA) Gains (Losses) on Sale of Assets & Investments (2021 - 2026) Analysis & Trends
For FY2023, Damora Therapeutics' Non Operating Investment Income came in at $231,000.
- In prior years, Damora Therapeutics' Non Operating Investment Income was -$259,000 in FY2022 and -$77,000 in FY2021.
- The Q2 2024 figure stands as the lowest quarterly Non Operating Investment Income since Q3 2022.
- On a year-over-year basis, Non Operating Investment Income has declined in each of the last three quarters.
- According to Business Quant data, Non Operating Investment Income for the three prior quarters was $32,000 (Q1 2024), $58,000 (Q4 2023) and $56,000 (Q3 2023).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gains on Sales (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Damora Therapeutics | 1.49 Bn | -364.52 Mn | - | 750,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 750,000.00 |
| Jun 30, 2024 | 2,000.00 |
| Mar 31, 2024 | 32,000.00 |
| Dec 31, 2023 | 58,000.00 |
| Sep 30, 2023 | 56,000.00 |
| Jun 30, 2023 | 25,000.00 |
| Mar 31, 2023 | 92,000.00 |
| Dec 31, 2022 | 183,000.00 |
| Sep 30, 2022 | -82,000.00 |
| Jun 30, 2022 | -155,000.00 |
| Mar 31, 2022 | -205,000.00 |
| Dec 31, 2021 | -54,000.00 |
| Sep 30, 2021 | 34,000.00 |
| Jun 30, 2021 | 23,000.00 |
| Mar 31, 2021 | -80,000.00 |
API Access
Damora Therapeutics Gains (Losses) on Sale of Assets & Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=DMRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "DMRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=DMRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();